Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-26-106216
Filing Date
2026-03-13
Accepted
2026-03-13 16:20:53
Documents
14
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A fblg-20251231.htm   iXBRL 10-K/A 1241769
2 EX-31.1 fblg-ex31_1.htm EX-31.1 12831
3 EX-31.2 fblg-ex31_2.htm EX-31.2 13316
  Complete submission text file 0001193125-26-106216.txt   1891071

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT fblg-20251231.xsd EX-101.SCH 59565
17 EXTRACTED XBRL INSTANCE DOCUMENT fblg-20251231_htm.xml XML 138156
Mailing Address 455 E. MEDICAL CENTER BLVD SUITE 300 SUITE 300 HOUSTON TX 77598
Business Address 455 E. MEDICAL CENTER BLVD SUITE 300 HOUSTON TX 77598 281-671-5150
FibroBiologics, Inc. (Filer) CIK: 0001958777 (see all company filings)

EIN.: 863329066 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-41934 | Film No.: 26752769
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)